Filing Details
- Accession Number:
- 0001562180-21-000647
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-29 20:03:44
- Reporting Period:
- 2021-01-27
- Accepted Time:
- 2021-01-29 20:03:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 897448 | Amarin Corp Plc | AMRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1289884 | B Steven Ketchum | C/O Amarin Pharma, Inc. 440 Us Highway 22 Bridgewater NJ 08807 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2021-01-27 | 25,389 | $1.02 | 556,893 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2021-01-27 | 8,332 | $2.50 | 565,225 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2021-01-27 | 5,797 | $2.50 | 571,022 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2021-01-27 | 52,938 | $2.50 | 623,960 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2021-01-27 | 29,427 | $2.50 | 653,387 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2021-01-27 | 23,436 | $1.40 | 676,823 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2021-01-27 | 47,605 | $2.95 | 724,428 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2021-01-27 | 85,313 | $3.80 | 809,741 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-01-27 | 278,237 | $8.01 | 531,504 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2021-01-27 | 143,392 | $8.01 | 388,112 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2021-01-29 | 26,000 | $0.00 | 414,112 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2021-01-29 | 12,733 | $0.00 | 426,845 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-01-29 | 19,971 | $7.50 | 406,874 | No | 4 | F | Direct | |
| Ordinary Shares | Acquisiton | 2021-01-29 | 1,528 | $0.00 | 408,402 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2021-01-29 | 1,528 | $0.00 | 409,930 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2021-01-29 | 1,564 | $7.50 | 408,366 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-01-27 | 25,389 | $0.00 | 25,389 | $1.02 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-01-27 | 8,332 | $0.00 | 8,332 | $2.50 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-01-27 | 5,797 | $0.00 | 5,797 | $2.50 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-01-27 | 52,938 | $0.00 | 52,938 | $2.50 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-01-27 | 29,427 | $0.00 | 29,427 | $2.50 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-01-27 | 23,436 | $0.00 | 23,436 | $1.40 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-01-27 | 47,605 | $0.00 | 47,605 | $2.95 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2021-01-27 | 85,313 | $0.00 | 85,313 | $3.80 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2021-01-29 | 26,000 | $0.00 | 26,000 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2021-01-29 | 12,733 | $0.00 | 12,733 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2021-01-29 | 1,528 | $0.00 | 1,528 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2021-01-29 | 1,528 | $0.00 | 1,528 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-02-02 | No | 4 | M | Direct | |
| 0 | 2025-07-06 | No | 4 | M | Direct | |
| 16,703 | 2025-07-06 | No | 4 | M | Direct | |
| 0 | 2025-07-06 | No | 4 | M | Direct | |
| 164,573 | 2025-07-06 | No | 4 | M | Direct | |
| 0 | 2026-01-31 | No | 4 | M | Direct | |
| 11,082 | 2027-01-31 | No | 4 | M | Direct | |
| 31,687 | 2028-02-01 | No | 4 | M | Direct | |
| 0 | No | 4 | M | Direct | ||
| 12,733 | No | 4 | M | Direct | ||
| 10,693 | No | 4 | M | Direct | ||
| 10,693 | No | 4 | M | Direct |
Footnotes
- Multiple reportable transactions are reported in the Form 4 including exercises of previously granted stock options, vesting of previously granted restricted stock units, and sale of certain shares. The market sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- On February 1, 2018, the Reporting Person was granted 78,000 Restricted Stock Units ("RSUs") under the Plan. These RSUs vest in three equal installments on each of January 31, 2019, January 31, 2020, and January 31, 2021. The third and final vesting event occurred on January 29, 2021.
- Not applicable.
- On February 1, 2019, the Reporting Person was granted 38,200 RSUs under the Plan. These RSUs vest in three equal installments on each of January 31, 2020, January 31, 2021, and January 31, 2022. The second vesting event occurred on January 29, 2021.
- Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
- As previously reported on February 27, 2020, on May 15, 2017, the Reporting Person was granted 220,000 RSUs under the Plan, of which the performance criteria related to two tranches representing 50% of the total award was deemed achieved on February 25, 2020 pursuant to reporting of audited net product revenues for 2019 exceeding $400 million. The tranches vest ratably over 36 months beginning September 30, 2018 subject to achievement of the performance criteria and continued employment of the Reporting Person as provided in the RSU Award Agreement between the Issuer and Reporting Person. The twenty-ninth vesting event occurred on January 29, 2021. The performance criteria related to the remaining 50% tranche has not yet been formally deemed achieved; such tranche has not lapsed as a result of achieving the other two tranches.
- Please see the section titled "Remarks" below for additional information.
- Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- On February 2, 2015, the Reporting Person was granted an option to purchase 93,750 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on February 28, 2015. This option was fully vested as of the date hereof.
- On July 6, 2015, the Reporting Person was granted an option to purchase 200,000 Ordinary Shares under the Plan. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof.
- On July 6, 2015, the Reporting Person was granted an option to purchase 180,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof.
- On July 6, 2015, the Reporting Person was granted an option to purchase 240,000 Ordinary Shares under the Plan. The vesting of the shares was subject to a certain performance milestone that was previously achieved. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on July 31, 2015. This option was fully vested as of the date hereof.
- On February 1, 2016, the Reporting Person was granted an option to purchase 125,000 Ordinary Shares under the Plan. The shares subject to this option vested in 48 equal monthly installments on the last day of each month starting on February 29, 2016. This option was fully vested as of the date hereof.
- On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2017.
- On February 1, 2018 the Reporting Person was granted an option to purchase 117,000 Ordinary Shares under the Plan. The shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2018.
Billionaire Hedge Funds
